Education
About Us
Working with TipRanks
Follow Us
Kobayashi Pharmaceutical Co (JP:4967)
OTHER OTC:4967
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 165.60B | ¥ 173.46B | ¥ 166.26B | ¥ 155.25B | ¥ 150.51B |
| Gross Profit | ¥ 87.60B | ¥ 96.38B | ¥ 92.33B | ¥ 88.77B | ¥ 85.27B |
| Operating Income | ¥ 24.86B | ¥ 25.78B | ¥ 26.67B | ¥ 26.07B | ¥ 25.94B |
| EBITDA | ¥ 21.96B | ¥ 33.65B | ¥ 33.33B | ¥ 32.49B | ¥ 30.76B |
| Net Income | ¥ 10.07B | ¥ 20.34B | ¥ 20.02B | ¥ 19.71B | ¥ 19.20B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 65.75B | ¥ 79.84B | ¥ 104.53B | ¥ 109.05B | ¥ 94.34B |
| Total Assets | ¥ 265.37B | ¥ 267.47B | ¥ 255.83B | ¥ 252.55B | ¥ 238.37B |
| Total Debt | ¥ 846.00M | ¥ 987.00M | ¥ 792.00M | ¥ 630.00M | ¥ 688.00M |
| Net Debt | ¥ -50.03B | ¥ -70.55B | ¥ -95.44B | ¥ -94.39B | ¥ -77.56B |
| Total Liabilities | ¥ 51.90B | ¥ 62.66B | ¥ 57.93B | ¥ 56.95B | ¥ 55.78B |
| Stockholders' Equity | ¥ 213.47B | ¥ 204.82B | ¥ 197.90B | ¥ 195.60B | ¥ 182.58B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -14.81B | ¥ 4.79B | ¥ 15.69B | ¥ 18.23B | ¥ 19.84B |
| Operating Cash Flow | ¥ 11.25B | ¥ 18.36B | ¥ 31.91B | ¥ 22.42B | ¥ 23.99B |
| Investing Cash Flow | ¥ -18.41B | ¥ -19.58B | ¥ -14.31B | ¥ 7.99B | ¥ -12.66B |
| Financing Cash Flow | ¥ -7.77B | ¥ -19.46B | ¥ -20.76B | ¥ -10.38B | ¥ -6.02B |